• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019年传染病学最新进展

Update in Infectious Diseases 2019.

作者信息

Candel F J, Rico C M, Díaz de la Torre I, Laguna B, Martínez-Jordán J, Medrano S, Escobar-Porcel M C, López-Delgado A, López-González L, Viñuela-Prieto J M, Matesanz M, González Del Castillo J, Arribi A

机构信息

Francisco Javier Candel, Clinical Microbiology and Infectious Diseases Department. Hospital Clínico San Carlos. IML Health Institute. Avda Profesor Martín Lagos s/n - 28040. Madrid, Spain.

出版信息

Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):1-9.

PMID:31475801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6755363/
Abstract

The IX Course of Antimicrobials and Infectious Diseases update included a review of the main issues in clinical microbiology, epidemiology and clinical aspects for a current approach of infectious pathology. The present introduction summarizes about the most important meetings related to infectious diseases during 2018 (ECCMID, IAS, ASM and ID Week). In addition, the course provides a practical information to focus on nosocomial infection models, with immunosuppressed patients or complex multidrug-resistant pathogens. The closing lecture of this year reviewed the infection during donation process.

摘要

第九届抗菌药物与传染病课程更新内容包括对临床微生物学、流行病学和临床方面的主要问题进行回顾,以形成当前感染病理学的研究方法。本引言总结了2018年期间与传染病相关的最重要会议(欧洲临床微生物学与传染病大会、国际艾滋病学会、美国微生物学会和感染病周)。此外,该课程提供了实用信息,重点关注医院感染模型,涉及免疫抑制患者或复杂的多重耐药病原体。今年的闭幕演讲回顾了捐赠过程中的感染情况。

相似文献

1
Update in Infectious Diseases 2019.2019年传染病学最新进展
Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):1-9.
2
Update in Infectious Diseases 2018.《2018年传染病学进展》
Rev Esp Quimioter. 2018 Sep;31 Suppl 1(Suppl 1):1-8.
3
[Update in Infectious Diseases 2016].
Rev Esp Quimioter. 2016 Sep;29 Suppl 1:1-5.
4
Pathology of infectious diseases: what does the future hold?传染病病理学:未来会怎样?
Virchows Arch. 2017 May;470(5):483-492. doi: 10.1007/s00428-017-2082-6. Epub 2017 Feb 10.
5
A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG (Italian Study Group on Severe Infections).一份关于医院感染和严重感染预防与管理的多学会立场文件:意大利传染病学会、意大利医院感染多学科学会、意大利化疗学会、意大利呼吸医学学会、意大利临床微生物学会、意大利微生物学会以及GISIG(意大利严重感染研究组)。
Int J Infect Dis. 2010 Oct;14 Suppl 4:S93-4. doi: 10.1016/j.ijid.2010.06.001. Epub 2010 Aug 14.
6
Highlights at the 28th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2018.2018年欧洲临床微生物学与传染病学会(ESCMID)第28届大会亮点
Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):16-21.
7
Using host defenses to fight infectious diseases.利用宿主防御机制对抗传染病。
Nat Biotechnol. 1996 May;14(5):587-90. doi: 10.1038/nbt0596-587.
8
[Nosocomial infections: epidemiology, pathogenesis, etiology, antibacterial therapy, and prophylaxis].[医院感染:流行病学、发病机制、病因、抗菌治疗及预防]
Antibiot Khimioter. 2005;50(12):19-28.
9
Conference Report 33rd European Congress on Clinical Microbiology and Infectious Diseases (ECCMID): New developments in pediatric oncology infectious disease supportive care.会议报告 33 届欧洲临床微生物学和传染病大会(ECCMID):儿科肿瘤传染病支持治疗的新进展。
Transpl Infect Dis. 2023 Dec;25(6):e14146. doi: 10.1111/tid.14146. Epub 2023 Sep 11.
10
Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases.
Expert Rev Anti Infect Ther. 2008 Feb;6(1):21-30. doi: 10.1586/14787210.6.1.21.

引用本文的文献

1
: emerging challenges in pathogenesis and drug resistance.发病机制和耐药性方面的新挑战
Future Microbiol. 2025 Mar;20(4):333-343. doi: 10.1080/17460913.2025.2457858. Epub 2025 Jan 27.
2
Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.新型N-三甲基壳聚糖纳米球作为破伤风疫苗稳定剂和防腐剂的生物学特性及应用
Clin Exp Vaccine Res. 2021 Jan;10(1):24-34. doi: 10.7774/cevr.2021.10.1.24. Epub 2021 Jan 31.
3
Epidemiological study of infections over the past 23 years.过去 23 年感染的流行病学研究。
Epidemiol Infect. 2020 Jul 24;148:e169. doi: 10.1017/S0950268820001624.

本文引用的文献

1
Highlights at the 28th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2018.2018年欧洲临床微生物学与传染病学会(ESCMID)第28届大会亮点
Rev Esp Quimioter. 2019 Sep;32 Suppl 2(Suppl 2):16-21.
2
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies.西班牙传染病和临床微生物学学会(SEIMC)、西班牙传染病研究网络(REIPI)和西班牙血液学和血液疗法学会(SEHH)关于血液系统恶性肿瘤患者中性粒细胞减少性发热管理的共识文件摘要
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Apr;38(4):174-181. doi: 10.1016/j.eimc.2019.01.013. Epub 2019 Mar 27.
3
SuperPolymyxin™ Medium for the Screening of Colistin-Resistant Gram-Negative Bacteria in Stool Samples.用于粪便样本中耐黏菌素革兰氏阴性菌筛查的SuperPolymyxin™培养基
Front Microbiol. 2018 Nov 21;9:2809. doi: 10.3389/fmicb.2018.02809. eCollection 2018.
4
Fourier transform infrared spectroscopy: unlocking fundamentals and prospects for bacterial strain typing.傅里叶变换红外光谱:解锁细菌株分型的基础和前景。
Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):427-448. doi: 10.1007/s10096-018-3431-3. Epub 2018 Nov 27.
5
Risk of infection associated with anti-TNF-α therapy.与抗 TNF-α 治疗相关的感染风险。
Expert Rev Anti Infect Ther. 2018 Dec;16(12):939-956. doi: 10.1080/14787210.2018.1544490. Epub 2018 Nov 7.
6
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.哌拉西林-他唑巴坦与美罗培南对产 ESBLs 的大肠埃希菌或肺炎克雷伯菌血流感染且对头孢曲松耐药患者 30 天死亡率的影响:一项随机临床试验。
JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163.
7
The use of faecal microbiota transplant as treatment for recurrent or refractory infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.粪便微生物群移植作为治疗复发性或难治性感染及其他潜在适应证的应用:联合英国胃肠病学会(BSG)和医疗保健感染学会(HIS)指南。
Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.
8
Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.西班牙马德里一家大学附属医院在 R-GNOSIS 项目中对定植患者中产碳青霉烯酶肠杆菌科的特征描述表明,随着时间的推移,克隆多样性不断增加,同时高风险克隆得以维持。
J Antimicrob Chemother. 2018 Nov 1;73(11):3039-3043. doi: 10.1093/jac/dky284.
9
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.血清学不一致的男男性伴侣中的病毒抑制和 HIV 传播:一项国际性、前瞻性、观察性队列研究。
Lancet HIV. 2018 Aug;5(8):e438-e447. doi: 10.1016/S2352-3018(18)30132-2. Epub 2018 Jul 17.
10
Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI.《曲霉菌引起的侵袭性疾病管理临床实践指南执行摘要:2018年GEMICOMED-SEIMC/REIPI更新版》
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Oct;37(8):535-541. doi: 10.1016/j.eimc.2018.03.018. Epub 2018 Jun 28.